Genetic reductions of β-site amyloid precursor protein-cleaving enzyme 1 and amyloid-β ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice

European Journal of Neuroscience

Volumn 31, Issue 1, 2010, Pages 110-118

  Devi, Latha ^a   Ohno, Masuo ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

secretase; APP transgenic; BACE1; Implicit memory; Knockout

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BETA SECRETASE 1; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FEAR; GENE MUTATION; GENETIC ENGINEERING; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TASTE AVERSION;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; AVOIDANCE LEARNING; BRAIN; CONDITIONING, CLASSICAL; DISEASE MODELS, ANIMAL; FEAR; HUMANS; MEMORY; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; MUTATION; PRESENILIN-1; RECEPTORS, CELL SURFACE; SPACE PERCEPTION; TASTE PERCEPTION;

EID: 72949094212     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2009.07031.x     Document Type: Article

References (49)

1. Ashe, K.H. (2001) Learning and memory in transgenic mice modeling Alzheimer's disease. Learn. Mem., 8, 301 308.
2. Berger-Sweeney, J., McPhie, D.L., Arters, J.A., Greenan, J., Oster-Granite, M.L. Neve, R.L. (1999) Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein. Brain Res. Mol. Brain Res., 66, 150 162.
3. Bermudez-Rattoni, F. (2004) Molecular mechanisms of taste-recognition memory. Nat. Rev. Neurosci., 5, 209 217.
4. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D.R., Price, D.L. Wong, P.C. (2001) BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nat. Neurosci., 4, 233 234.
5. Carlesimo, G.A. Oscar-Berman, M. (1992) Memory deficits in Alzheimer's patients: a comprehensive review. Neuropsychol. Rev., 3, 119 169.
6. Chang, W.P., Downs, D., Huang, X.P., Da, H., Fung, K.M. Tang, J. (2007) Amyloid-β reduction by memapsin 2 (β-secretase) immunization. FASEB J., 21, 3184 3196. (Pubitemid 47565537)
7. Choi, S.H., Park, C.H., Koo, J.W., Seo, J.H., Kim, H.S., Jeong, S.J., Lee, J.H., Kim, S.S. Suh, Y.H. (2001) Memory impairment and cholinergic dysfunction by centrally administered Aβ and carboxyl-terminal fragment of Alzheimer's APP in mice. FASEB J., 15, 1816 1818.
8. Ding, H.K., Teixeira, C.M. Frankland, P.W. (2008) Inactivation of the anterior cingulate cortex blocks expression of remote, but not recent, conditioned taste aversion memory. Learn. Mem., 15, 290 293.
9. Eriksen, J.L. Janus, C.G. (2007) Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav. Genet., 37, 79 100.
10. Fanselow, M.S. (2000) Contextual fear, gestalt memories, and the hippocampus. Behav. Brain Res., 110, 73 81.
11. Fleischman, D.A., Wilson, R.S., Gabrieli, J.D., Schneider, J.A., Bienias, J.L. Bennett, D.A. (2005) Implicit memory and Alzheimer's disease neuropathology. Brain, 128, 2006 2015.
12. Franklin, K.B.J. Paxinos, G. (2008) The Mouse Brain in Stereotaxic Coordinates. Academic Press, New York.
13. Fukumoto, H., Cheung, B.S., Hyman, B.T. Irizarry, M.C. (2002) β-Secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol., 59, 1381 1389.
14. Gotz, J. Ittner, L.M. (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci., 9, 532 544.
15. Hebert, S.S., Horre, K., Nicolai, L., Papadopoulou, A.S., Mandemakers, W., Silahtaroglu, A.N., Kauppinen, S., Delacourte, A. De Strooper, B. (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression. Proc. Natl Acad. Sci. USA, 105, 6415 6420.
16. Holsinger, R.M., McLean, C.A., Beyreuther, K., Masters, C.L. Evin, G. (2002) Increased expression of the amyloid precursor β-secretase in Alzheimer's disease. Ann. Neurol., 51, 783 786.
17. Janus, C., Welzl, H., Hanna, A., Lovasic, L., Lane, N., St George-Hyslop, P. Westaway, D. (2004) Impaired conditioned taste aversion learning in APP transgenic mice. Neurobiol. Aging, 25, 1213 1219. (Pubitemid 39094024)
18. Jelicic, M., Bonebakker, A.E. Bonke, B. (1995) Implicit memory performance of patients with Alzheimer's disease: a brief review. Int. Psychogeriatr., 7, 385 392.
19. Josselyn, S.A., Kida, S. Silva, A.J. (2004) Inducible repression of CREB function disrupts amygdala-dependent memory. Neurobiol. Learn. Mem., 82, 159 163.
20. Kimura, R. Ohno, M. (2009) Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol. Dis., 33, 229 235.
21. Kobayashi, D.T. Chen, K.S. (2005) Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease. Genes Brain Behav., 4, 173 196.
22. LaFerla, F.M. Oddo, S. (2005) Alzheimer's disease: Aβ, tau and synaptic dysfunction. Trends Mol. Med., 11, 170 176.
23. Laird, F.M., Cai, H., Savonenko, A.V., Farah, M.H., He, K., Melnikova, T., Wen, H., Chiang, H.C., Xu, G., Koliatsos, V.E., Borchelt, D.R., Price, D.L., Lee, H.K. Wong, P.C. (2005) BACE1, a major determinant of selective vulnerability of the brain to amyloid-β amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J. Neurosci., 25, 11693 11709.
24. Lee, K.W., Im, J.Y., Song, J.S., Lee, S.H., Lee, H.J., Ha, H.Y., Koh, J.Y., Gwag, B.J., Yang, S.D., Paik, S.G. Han, P.L. (2006) Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein. Neurobiol. Dis., 22, 10 24.
25. Li, R., Lindholm, K., Yang, L.B., Yue, X., Citron, M., Yan, R., Beach, T., Sue, L., Sabbagh, M., Cai, H., Wong, P., Price, D. Shen, Y. (2004) Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients. Proc. Natl Acad. Sci. USA, 101, 3632 3637.
26. McConlogue, L., Buttini, M., Anderson, J.P., Brigham, E.F., Chen, K.S., Freedman, S.B., Games, D., Johnson-Wood, K., Lee, M., Zeller, M., Liu, W., Motter, R. Sinha, S. (2007) Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice. J. Biol. Chem., 282, 26326 26334.
27. McGowan, E., Eriksen, J. Hutton, M. (2006) A decade of modeling Alzheimer's disease in transgenic mice. Trends Genet., 22, 281 289.
28. Meiran, N. Jelicic, M. (1995) Implicit memory in Alzheimer's disease: a meta-analysis. Neuropsychology, 9, 291 303.
29. Nalbantoglu, J., Tirado-Santiago, G., Lahsaini, A., Poirier, J., Goncalves, O., Verge, G., Momoli, F., Welner, S.A., Massicotte, G., Julien, J.P. Shapiro, M.L. (1997) Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature, 387, 500 505.
30. O'Connor, T., Sadleir, K.R., Maus, E., Velliquette, R.A., Zhao, J., Cole, S.L., Eimer, W.A., Hitt, B., Bembinster, L.A., Lammich, S., Lichtenthaler, S.F., Hebert, S.S., De Strooper, B., Haass, C., Bennett, D.A. Vassar, R. (2008) Phosphorylation of the translation initiation factor eIF2α increases BACE1 levels and promotes amyloidogenesis. Neuron, 60, 988 1009.
31. Oakley, H., Cole, S.L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., Berry, R. Vassar, R. (2006) Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci., 26, 10129 10140.
32. Ohno, M. (2006) Genetic and pharmacological basis for therapeutic inhibition of β- and γ-secretases in mouse models of Alzheimer's memory deficits. Rev. Neurosci., 17, 429 454.
33. Ohno, M. 2008. β-Secretase as a prime therapeutic target for Alzheimer's disease: a perspective from mouse model studies. In Araki, W. (Ed Recent Advances in the Biology of Secretases, Key Proteases in Alzheimer's Disease. Research Signpost, Kerala, pp. 1 25.
34. Ohno, M. Kimura, R. (2008) Impacts of partial reduction of BACE1 on synaptic and memory dysfunction in Alzheimer's transgenic mice. Alzheimers Dement., 4 (Suppl 2 T233 T234.
35. Ohno, M., Frankland, P.W., Chen, A.P., Costa, R.M. Silva, A.J. (2001) Inducible, pharmacogenetic approaches to the study of learning and memory. Nat. Neurosci., 4, 1238 1243.
36. Ohno, M., Sametsky, E.A., Younkin, L.H., Oakley, H., Younkin, S.G., Citron, M., Vassar, R. Disterhoft, J.F. (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron, 41, 27 33.
37. Ohno, M., Chang, L., Tseng, W., Oakley, H., Citron, M., Klein, W.L., Vassar, R. Disterhoft, J.F. (2006) Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Eur. J. Neurosci., 23, 251 260.
38. Ohno, M., Cole, S.L., Yasvoina, M., Zhao, J., Citron, M., Berry, R., Disterhoft, J.F. Vassar, R. (2007) BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiol. Dis., 26, 134 145.
39. Pistell, P.J., Zhu, M. Ingram, D.K. (2008) Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease. Neuroscience, 152, 594 600.
40. Singer, O., Marr, R.A., Rockenstein, E., Crews, L., Coufal, N.G., Gage, F.H., Verma, I.M. Masliah, E. (2005) Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat. Neurosci., 8, 1343 1349.
41. Song, D.K., Won, M.H., Jung, J.S., Lee, J.C., Kang, T.C., Suh, H.W., Huh, S.O., Paek, S.H., Kim, Y.H., Kim, S.H. Suh, Y.H. (1998) Behavioral and neuropathologic changes induced by central injection of carboxyl-terminal fragment of β-amyloid precursor protein in mice. J. Neurochem., 71, 875 878.
42. Squire, L.R. (1992) Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev., 99, 195 231.
43. Tesco, G., Koh, Y.H., Kang, E.L., Cameron, A.N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.H., Zhong, Z., Shen, Y., Simpkins, J.W. Tanzi, R.E. (2007) Depletion of GGA3 stabilizes BACE and enhances β-secretase activity. Neuron, 54, 721 737.
44. Wang, W.X., Rajeev, B.W., Stromberg, A.J., Ren, N., Tang, G., Huang, Q., Rigoutsos, I. Nelson, P.T. (2008) The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of β-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci., 28, 1213 1223.
45. Welzl, H., D'Adamo, P. Lipp, H.P. (2001) Conditioned taste aversion as a learning and memory paradigm. Behav. Brain Res., 125, 205 213.
46. Yamamoto, T. Fujimoto, Y. (1991) Brain mechanisms of taste aversion learning in the rat. Brain Res. Bull., 27, 403 406.
47. Yang, L.B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X.L., Beach, T., Sue, L., Wong, P., Price, D., Li, R. Shen, Y. (2003) Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med., 9, 3 4.
48. Zacchetti, D., Chieregatti, E., Bettegazzi, B., Mihailovich, M., Sousa, V.L., Grohovaz, F. Meldolesi, J. (2007) BACE1 expression and activity: relevance in Alzheimer's disease. Neurodegenr. Dis., 4, 117 126.
49. Zhao, J., Fu, Y., Yasvoina, M., Shao, P., Hitt, B., O'Connor, T., Logan, S., Maus, E., Citron, M., Berry, R., Binder, L. Vassar, R. (2007) β-Site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J. Neurosci., 27, 3639 3649.